SCHEMBL8474192

SCHEMBL8474192

O=C(CC1CCC2(CC1)OCCO2)N1CCN(c2ccccn2)CC1

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 13/20 0.70
HSD17B10 Q99714 9/20 0.70
ALDH1A1 P00352 9/20 0.70
HPGD P15428 5/20 0.56
CYP3A4 P08684 2/20 0.56
CYP2C9 P11712 2/20 0.56
LMNA P02545 2/20 0.56
HTT P42858 2/20 0.56
MAPK1 P28482 2/20 0.56
CYP1A2 P05177 1/20 0.56
CYP2D6 P10635 1/20 0.56
CYP2C19 P33261 1/20 0.56
RECQL P46063 1/20 0.53
CASP1 P29466 1/20 0.51
POLB P06746 1/20 0.50
KMT2A Q03164 2/20 0.49
SMN1; SMN2 Q16637 2/20 0.49
RAB9A P51151 2/20 0.48
NPC1 O15118 1/20 0.48
TSHR P16473 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7791945 0.81 HRH3 (0.47) KDM4EHSD17B10ALDH1A1CYP3A4CYP2C9
SCHEMBL5052466 0.76 KDM4E (0.72) KDM4EHSD17B10ALDH1A1HPGDCYP3A4
SCHEMBL3161270 0.75 ALDH1A1 (0.56) KDM4EHSD17B10ALDH1A1HPGDCYP3A4
SCHEMBL7803644 0.75 KDM4E (0.58) KDM4EHSD17B10ALDH1A1HPGDCYP3A4
SCHEMBL3847579 0.73 MAPT (0.55) HSD17B10ALDH1A1CYP3A4CYP2C9LMNA
SCHEMBL596065 0.73 KDM4E (0.72) KDM4EHSD17B10ALDH1A1HPGDCYP3A4
SCHEMBL19134108 0.72 FFAR4 (0.65) KDM4EHSD17B10ALDH1A1HPGDCYP3A4
SCHEMBL15007834 0.72 KDM4E (0.70) KDM4EHSD17B10ALDH1A1HPGDCYP3A4
SCHEMBL12781875 0.72 KDM4E (0.70) KDM4EHSD17B10ALDH1A1HPGDCYP3A4
SCHEMBL15630682 0.72 KDM4E (0.70) KDM4EHSD17B10ALDH1A1HPGDCYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5977110-A Substituted cyclohexylamines as central nervous systems agents WARNER-LAMBERT COMPANY (US) 1999-11-02 US disclosed
WO-1997011070-A1 SUBSTITUTED CYCLOHEXYLAMINES AS CENTRAL NERVOUS SYSTEM AGENTS WARNER-LAMBERT COMPANY (US) 1997-03-27 WO disclosed
WO-1992012977-A1 SUBSTITUTED INDOLES AS CENTRAL NERVOUS SYSTEM AGENTS WARNER-LAMBERT COMPANY (US) 1992-08-06 WO disclosed
US-5124332-A Dopaminergic agents, hypotensive agents WARNER-LAMBERT COMPANY (US) 1992-06-23 US disclosed
US-4988699-A Treatment of psychological disorders such as schizophrenia, as antipsychotic agents and hypotensive agents WARNER-LAMBERT COMPANY (US) 1991-01-29 US disclosed